dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Casanova Salas, Irene |
dc.contributor.author | Athie Cuervo, Alejandro |
dc.contributor.author | Boutros, Paul C. |
dc.contributor.author | Del Re, Marzia |
dc.contributor.author | Miyamoto, David T. |
dc.contributor.author | Pienta, Kenneth J. |
dc.contributor.author | Mateo Valderrama, Joaquim |
dc.date.accessioned | 2022-02-24T16:19:45Z |
dc.date.available | 2022-02-24T16:19:45Z |
dc.date.issued | 2021-06 |
dc.identifier.citation | Casanova-Salas I, Athie A, Boutros PC, Del Re M, Miyamoto DT, Pienta KJ, et al. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer. Eur Urol. 2021 Jun;79(6):762-771. |
dc.identifier.issn | 0302-2838 |
dc.identifier.uri | https://hdl.handle.net/11351/7078 |
dc.description | ADN tumoral circulant; Medicina de precisió; Càncer de pròstata |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | European Urology;79(6) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pròstata - Càncer - Aspectes genètics |
dc.subject | Biòpsia |
dc.subject | Pròstata - Càncer - Presa de decisions |
dc.subject.mesh | Prostatic Neoplasms |
dc.subject.mesh | /genetics |
dc.subject.mesh | Liquid Biopsy |
dc.subject.mesh | Clinical Decision-Making |
dc.title | Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.eururo.2020.12.037 |
dc.subject.decs | neoplasias de la próstata |
dc.subject.decs | /genética |
dc.subject.decs | biopsia líquida |
dc.subject.decs | toma de decisiones clínicas |
dc.relation.publishversion | https://doi.org/10.1016/j.eururo.2020.12.037 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Casanova-Salas I, Athie A, Mateo J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Boutros PC] Departments of Human Genetics and Urology, Institute for Precision Health and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA. [Del Re M] Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy. [Miyamoto DT] Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. [Pienta KJ] The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
dc.identifier.pmid | 33422353 |
dc.identifier.wos | 000651453500029 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT008%2F18%2F00185 |
dc.relation.projectid | info:eu-repo/grantAgreement/EC/H2020/847648 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F01384 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |